Lithium Ion

Lithium Ion

SCHEMBL8690674

CCCCO[Al+2].[H-].[H-].[H-].[Li+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1079512 0.97
SCHEMBL11851591 0.94
SCHEMBL15669782 0.90
Hydrochloric Acid SCHEMBL4627112 0.90
Bromide SCHEMBL9114116 0.90
SCHEMBL11853665 0.85
Hydrochloric Acid SCHEMBL9114403 0.81
Bromide SCHEMBL9113001 0.81
Hydrochloric Acid SCHEMBL9113756 0.79 TSHR (0.47)
SCHEMBL468634 0.78 ADRB2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-62230745-A None JP disclosed
US-5770575-A Nipecotic acid derivatives as antithrombotic compounds ORTHO PHARMACEUTICAL CORPORATION (US) 1998-06-23 US disclosed
EP-0746545-A1 NIPECOTIC ACID DERIVATIVES AS ANTITHROMBIC COMPOUNDS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-12-11 EP disclosed
WO-1995025091-A2 NIPECOTIC ACID DERIVATIVES AS ANTITHROMBIC COMPOUNDS ORTHO PHARMACEUTICAL CORPORATION (US) 1995-09-21 WO disclosed
JP-S62230745-A PRODUCTION OF 2-HYDROXYMETHYL-2,5,12-TRIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHACENE-6,11-DIONE SAGAMI CHEM RES CENTER 1987-10-09 JP disclosed